iBio, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-13.2M | $-14.5M | $1.3M | $1.0M |
| FY2018 | $-13.5M | $-14.4M | $934.0K | $770.0K |
| FY2019 | $-14.0M | $-14.9M | $920.0K | $241.0K |
| FY2020 | $-13.3M | $-14.4M | $1.1M | $388.0K |
| FY2021 | $-30.1M | $-35.0M | $4.9M | $1.6M |
| FY2022 | $-37.5M | $-44.8M | $7.3M | $4.4M |
| FY2023 | $-30.4M | $-36.2M | $5.7M | $4.4M |
| FY2024 | $-18.6M | $-18.8M | $210.0K | $2.0M |
| FY2025 | $-15.3M | $-15.3M | $16.0K | $1.5M |
| FY2026 | $-23.2M | $-23.8M | $578.0K | $1.4M |